Hu Hai-Tao, Ma Fu-Hai, Xiong Jian-Ping, Li Yang, Jin Peng, Liu Hao, Ma Shuai, Kang Wen-Zhe, Tian Yan-Tao
Department of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, Beijing Province, China.
World J Gastrointest Surg. 2022 Feb 27;14(2):161-173. doi: 10.4240/wjgs.v14.i2.161.
Laparoscopic total gastrectomy (LTG) has drawn increasing attention over the years. Although LTG has shown surgical benefits compared to open TG (OTG) in early stage gastric cancer (GC), little is known about the surgical and oncological outcomes of LTG for advanced GC following neoadjuvant therapy (NAT).
To compare the long- and short-term outcomes of advanced GC patients who underwent LTG OTG following NAT.
Advanced GC patients who underwent TG following NAT between April 2011 and May 2018 at the Cancer Hospital of the Chinese Academy of Medical Sciences were enrolled and stratified into two groups: LTG and OTG. Propensity score matching analysis was performed at a 1:1 ratio to overcome possible bias.
In total, 185 patients were enrolled (LTG: 78; OTG: 109). Of these, 138 were paired after propensity score matching. After adjustment for propensity score matching, baseline parameters were similar between the two groups. Compared to OTG, LTG was associated with a significantly shorter length of hospital stay ( = 0.012). The rates of R0 resection, lymph node harvest, and postoperative morbidity did not significantly differ between the two groups. Overall survival (OS) outcomes were comparable between the two groups. Pathological T and N stages were found to be independent risk factors for OS.
LTG can be a feasible method for advanced GC patients following NAT, as it appears to be associated with better short- and comparable long-term outcomes compared to OTG.
近年来,腹腔镜全胃切除术(LTG)越来越受到关注。尽管在早期胃癌(GC)中,与开放全胃切除术(OTG)相比,LTG已显示出手术优势,但对于新辅助治疗(NAT)后晚期GC患者接受LTG的手术和肿瘤学结局知之甚少。
比较接受NAT后行LTG和OTG的晚期GC患者的短期和长期结局。
纳入2011年4月至2018年5月在中国医学科学院肿瘤医院接受NAT后行TG的晚期GC患者,并将其分为两组:LTG组和OTG组。采用1:1比例的倾向评分匹配分析以克服可能的偏倚。
共纳入185例患者(LTG组:78例;OTG组:109例)。其中,138例在倾向评分匹配后配对。在调整倾向评分匹配后,两组的基线参数相似。与OTG相比,LTG组的住院时间明显缩短(P = 0.012)。两组的R0切除率、淋巴结清扫率和术后发病率无显著差异。两组的总生存(OS)结局相当。病理T和N分期被发现是OS的独立危险因素。
对于接受NAT后的晚期GC患者,LTG可能是一种可行的方法,因为与OTG相比,它似乎具有更好的短期结局和相当的长期结局。